Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study-Reference-Cited by-同舟云学术

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

Published:2003-09 Issue:1-2 Volume:142 Page:130-136
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Confalonieri Paolo,Oliva Laura,Andreetta Francesca,Lorenzoni Rossella,Dassi Patrizia,Mariani Elisabetta,Morandi Lucia,Mora Marina,Cornelio Ferdinando,Mantegazza Renato

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference24 articles.

1. Multiplex Western blotting system for the analysis of muscular dystrophy proteins;Anderson;Am. J. Pathol.,1999

2. Monoclonal antibody analysis of mononuclear cells in myopathies: I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells;Arahata;Ann. Neurol.,1984

3. Dysferlin deletion in SJL mice (SJLz-Dysf) defines a natural model for limb girdle muscular dystrophy 2B;Bittner;Nat. Genet.,1999

4. Making sense of the limb-girdle muscular dystrophies;Bushby;Brain,1999

5. The limb-girdle muscular dystrophies—multiple genes multiple mechanisms;Bushby;Hum. Mol. Genet.,1999

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical expression in idiopathic inflammatory myopathies at a single center in Vietnam;Journal of Pathology and Translational Medicine;2024-07-15

2. Miyoshi myopathy associated with spine rigidity and multiple contractures: a case report;BMC Musculoskeletal Disorders;2024-02-16

3. Complement and MHC patterns can provide the diagnostic framework for inflammatory neuromuscular diseases;Acta Neuropathologica;2024-01-12

4. Mimics of Immune-Mediated Myopathy;Immune-Mediated Myopathies and Neuropathies;2023

5. The Role of the Muscle Biopsy in the Era of Genetic Diagnosis;Current Clinical Neurology;2023